Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Salestools Logo

Salestools

Der #1 KI-Agent für Vertriebsteams und Go-to-Market-Teams. Verkaufen Sie mehr, schneller, mit weniger Aufwand.

Produkt

  • KI-Vertriebsagenten
  • Intent-Daten
  • Technologiedaten
  • Besucher-Tracking
  • Co-Pilot
  • Social Selling

Lösungen

  • Kundenservice
  • E-Commerce
  • SaaS
  • Enterprise
  • Kleinunternehmen

Ressourcen

  • Der Report
  • Dokumentation
  • API-Referenz
  • Hilfecenter
  • Blog
  • Fallstudien
  • Webinare

Unternehmen

  • Über uns
  • Karriere
  • Presse
  • Kontakt
  • Partner

Unsere Standorte

  • New York, HQ
  • Bukarest, KI-Forschungslabor
  • Zug, Schweiz

© 2025 Salestools. Alle Rechte vorbehalten.

Datenbedingungen & SicherheitDatenschutzerklärungNutzungsbedingungen
Alle Systeme betriebsbereit
Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Back to The Report
Fundraising

Mercor

Mercor Raises $350M in Series C

2021
Founded
200+
Employees
San Francisco, CA
Updated October 29, 2025
2 min read

Quick Facts

Mercor Raises $350M in Series C


Mercor has successfully raised $350M in a Series C at a $10B valuation led by Felicis, Robinhood Ventures, General Catalyst, Benchmark.


Company Overview


Mercor is a AI/ML company headquartered in San Francisco, CA, founded in 2021 with 200+ employees.


AI-enabled hiring platform matching companies with vetted talent using intelligent screening


Fundraising Details


  • Amount Raised: $350M
  • Round Type: Series C
  • Valuation: $10B
  • Date: 2025-10-29
  • Investors: Felicis, Robinhood Ventures, General Catalyst, Benchmark

About Mercor


AI-enabled hiring platform matching companies with vetted talent using intelligent screening The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: San Francisco, CA
  • Founded: 2021
  • Team Size: 200+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in Mercor's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. Mercor's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $10B valuation marks an important milestone for Mercor, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, Mercor is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-10-29. For more information about Mercor, visit their headquarters at San Francisco, CA.

Topics

Fundraising(2912)AI/ML(481)Series C(291)Mercor

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million